Clinical Trial

A Study to Identify and Characterize Adults and Pediatric Participants With Cat and/or Birch Allergy

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this Patient Identification and Characterization (PIC) study is to collect information and perform limited allergy-related procedures to determine if participants can qualify for cat and/or birch tree pollen allergy clinical research studies in the future. The study is also looking at how cat and/or birch tree pollen allergies have affected overall health.
Trial Details
NCT Number NCT07710846
Lead Sponsor Regeneron Pharmaceuticals
Conditions Conjunctivitis Allergic
Enrollment 1,500 participants
Start Date 2026-08-17
Primary Completion 2028-01-10 (estimated)
Study Completion 2028-01-10 (estimated)
Updated on ClinicalTrials.gov 2026-07-17